WallStreetZenWallStreetZen

NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alan H. AuerbachPresident and CEO2024-01-0341,396$4.49
$185.70kSell
Alvin F. WongChief Scientific Officer2024-01-037,733$4.49
$34.69kSell
Jeffrey Jerome LudwigChief Commercial Officer2024-01-0312,956$4.49
$58.12kSell
Maximo F. NouguesChief Financial Officer2024-01-0315,682$4.49
$70.35kSell
Douglas M. HuntOfficer2024-01-038,358$4.49
$37.49kSell
Alvin F. WongChief Scientific Officer2023-12-04280$3.76
$1.05kSell
Michael Patrick MillerDirector2023-11-0725,000$2.83
$70.80kSell
Alan H. AuerbachPresident and CEO2023-07-0360,698$3.31
$200.97kSell
Douglas M. HuntOfficer2023-07-037,809$3.31
$25.86kSell
Jeffrey Jerome LudwigChief Commercial Officer2023-07-0312,103$3.31
$40.07kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC18.41%8,879,139$41.29MInsider
Alan H. Auerbach14.73%7,104,320$33.04MInsider
Vanguard Group Inc7.24%3,491,249$16.23MInstitution
Adage Capital Partners LP6.63%3,200,000$14.88MInsider
Millennium Management LLC6.57%3,167,463$14.73MInstitution
Frazier Life Sciences Management LP5.84%2,816,294$13.10MInstitution
Acadian Asset Management LLC4.06%1,956,513$9.10MInstitution
Renaissance Technologies LLC3.59%1,729,413$8.04MInstitution
Camber Capital Management LP3.42%1,650,000$7.67MInstitution
Blackrock Inc3.35%1,617,558$7.52MInstitution

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI58.01%41.99%Net Selling
HOWL51.91%48.09%
OPT1.43%0.00%
CDT2.18%73.51%
CLLS13.73%0.00%

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 61.35% institutional shareholders, 44.40% Puma Biotechnology insiders, and 0.00% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 18.41% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $39.16M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.